COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
What the US Equal Employment Opportunity Commission (EEOC) updated in its June 17 guidance to employers on COVID-19 testing.
An interview with Mayo Clinic’s Elitza Theel, PhD, presents an overview of the state of convalescent plasma treatment for COVID-19.
Explanation of preanalytical issues with SARS-CoV-2 (COVID-19) testing in clinical laboratories and what to expect in the event of a second wave of infections in the fall.
At-home SARS-CoV-2 warning letters and implications for clinical laboratories and pathologists.
Overview of complaints around COVID-19 test payment expectations and attempts to reduce health insurers’ legislative and regulatory requirements.
In an exclusive interview, Frederick (Fritz) Kiechle, MD, PhD, explains how and why saliva has emerged as a sample type for detecting SARS-CoV-2, the coronavirus that causes COVID-19.
What the US Equal Employment Opportunity Commission (EEOC) updated in its June 17 guidance to employers on COVID-19 testing.
An interview with Mayo Clinic’s Elitza Theel, PhD, presents an overview of the state of convalescent plasma treatment for COVID-19.
Explanation of preanalytical issues with SARS-CoV-2 (COVID-19) testing in clinical laboratories and what to expect in the event of a second wave of infections in the fall.
At-home SARS-CoV-2 warning letters and implications for clinical laboratories and pathologists.
Overview of complaints around COVID-19 test payment expectations and attempts to reduce health insurers’ legislative and regulatory requirements.
In an exclusive interview, Frederick (Fritz) Kiechle, MD, PhD, explains how and why saliva has emerged as a sample type for detecting SARS-CoV-2, the coronavirus that causes COVID-19.
